MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Free Cash flow
-$182,487
Unit: Dollar
Positive Cash Flow Breakdown
    • Change in the fair value of deri...
    • Accounts payable and accrued lia...
    • Interest expense
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Proceeds from related party loan...
    • Change in the fair value of obli...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,909,042
-382,021
-7,549,585
-1,477,811
Amortization and depreciation included in cost of goods sold
50,088
-15,808
-
-
Amortization and depreciation
34,280
-
-
0
Shares to be issued for services included in general and administrative
-
-
142,800
-
Amortization and depreciation
-
15,808
-
-
Change in the fair value of derivative conversion feature
-1,599,738
801,038
-1,452,721
602,569
Change in the fair value of obligation to issue shares
1,394,053
-317,527
607,971
-2,095,299
Foreign exchange gain
-
-
-4,832
71,084
Unrealized foreign exchange loss
-78,085
-
-
-
Interest expense
349,008
475,617
179,423
506,331
Imputed interest expense
-
311,542
303,388
187,242
Loss on the extinguishment of debt
-
-
0
-
Loss on impairment of investment
-
-
4,518,127
-
Loss on the extinguishment of debt
-
-
-
0
Gain on write-off of accounts payable and accrued liabilities
-
-
410,430
-
Foreign exchange loss
-
31,084
-
-
Imputed interest expense
605,005
-
-
-
Other expense
0
0
0
0
Loss on impairment of inventory included in cost of goods sold
218,752
493,722
478,067
1,506,292
Goods and services tax receivable
660
-10,435
12,204
-1,079
Accounts receivable
269,084
358,784
430,738
479,360
Accounts payable and accrued liabilities
-
703,456
2,877,890
-
Inventory
632,040
281,019
697,362
285,478
Deferred revenue
37,202
-260,343
260,561
0
Royalty payable
63,875
131,220
13,715
289,810
Accounts payable and accrued liabilities
859,139
-
-
293,235
Accrued interest
-
-
0
0
Cash used in operating activities
-127,369
-243,656
1,061,442
-802,700
Proceeds from issuance of share purchase warrants
-
-
-
0
Proceeds from notes payable
-
-
0
0
Proceeds from related party loans
-
242,485
794,269
-
Proceeds from convertible notes
-
-
0
0
Purchases of equipment
55,118
-
5,519
-
Cash used in investing activities
-55,118
-
794,269
-
Repayment of convertible notes
-
-
-
0
Proceeds from related party loans
-1,424,421
-
-
786,652
Cash provided by financing activities
182,409
242,485
-1,854,834
786,652
Net change in cash
-78
-1,171
877
-16,048
Cash, beginning of period
633
1,804
927
2,156
Cash, end of period
555
633
1,804
927
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

something is missing$1,606,830 Cash provided byfinancing activities$182,409 (-82.83%↓ Y/Y)Canceled cashflow$1,424,421 Net change in cash-$78 (-100.53%↓ Y/Y)Canceled cashflow$182,409 Change in the fair valueof derivative...-$1,599,738 (-368.74%↓ Y/Y)Accounts payable andaccrued liabilities$859,139 (123.44%↑ Y/Y)Imputed interestexpense$605,005 Interest expense$349,008 (-72.58%↓ Y/Y)something is missing$282,514 Loss on impairment ofinventory included in cost...$218,752 (-79.09%↓ Y/Y)Unrealized foreignexchange loss-$78,085 Royalty payable$63,875 (14.89%↑ Y/Y)Deferred revenue$37,202 Amortization anddepreciation$34,280 Proceeds from relatedparty loans-$1,424,421 (-234.04%↓ Y/Y)Cash used inoperating activities-$127,369 (87.84%↑ Y/Y)Canceled cashflow$4,127,598 Cash used ininvesting activities-$55,118 Net loss-$1,909,042 (9.27%↑ Y/Y)Change in the fair valueof obligation to...$1,394,053 (-27.65%↓ Y/Y)Inventory$632,040 (-37.12%↓ Y/Y)Accounts receivable$269,084 (165.90%↑ Y/Y)Amortization anddepreciation included in cost...$50,088 Goods and services taxreceivable$660 (-85.32%↓ Y/Y)Purchases of equipment$55,118

CANNAPHARMARX, INC. (CPMD)

CANNAPHARMARX, INC. (CPMD)